These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8053282)

  • 1. Carvedilol in the treatment of mild to moderate hypertension: experience with ambulatory blood pressure monitoring.
    Biston P; Van de Borne P; Mélot C; Smekens P; Marinus W; Degaute JP
    Acta Cardiol; 1994; 49(2):145-55. PubMed ID: 8053282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
    Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O; Ertem B; Altun A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
    Dupont AG; Schoors DF; Venuti RP
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S153-7. PubMed ID: 1974507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy.
    White WB; Lund-Johansen P; Omvik P
    J Hypertens Suppl; 1993 Jun; 11(4):S75-80. PubMed ID: 8377035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP; Durier P; Bussiere JL; Gayet JL
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
    Weber MA; Bakris GL; Tarka EA; Iyengar M; Fleck R; Sica DA
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12):840-9. PubMed ID: 17170609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acebutolol with and without hydrochlorothiazide versus carvedilol with and without hydrochlorothiazide in black patients with mild to moderate systemic hypertension.
    Radevski IV; Valtchanova SP; Candy GP; Tshele EF; Sareli P
    Am J Cardiol; 1999 Jul; 84(1):70-5. PubMed ID: 10404854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR; de Vries Robles P; Venuti RP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
    Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study.
    Ayashi S; Assareh AR; Jalali MT; Olapour S; Yaghooti H
    Indian J Pharmacol; 2016; 48(4):372-376. PubMed ID: 27756946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Langdon CG; Baxter GA; Young PH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.